Evaluation of Gynecological Acceptability of 3 Health Care Products

NCT ID: NCT04327947

Last Updated: 2020-04-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

65 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-11-06

Study Completion Date

2020-02-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The research was conduct with 3 different products for use in the intimate region in up to 70 research participants, that use the investigational product by 35 ± 2 days. The subjects were follow up throughout the study by a gynecologist for verification of safety, effectiveness and possible adverse events.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

At this study, 70 female participants, 18 to 70 years, healthy with complaints of vaginal dryness used the 3 investigational product, each one by 9 days. Between the changes of product use, there were 4 days of wash out. At the 9th day, the participants answered assessment questionnaire.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrophic Vaginitis Vaginal Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Clinical trial, triple arm, randomized
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

women, 18-39 y

Health volunteers, 18-39 y, with vaginal dryness

Group Type EXPERIMENTAL

Hyaluronic acid - Research product 1

Intervention Type OTHER

Health care product (intimate gel)

Hyaluronic acid - Research product 2

Intervention Type OTHER

Health care product (intimate gel)

Hyaluronic acid - Comparator product

Intervention Type OTHER

Health care product (intimate gel)

premenopause women

Health volunteers, 40 years to premenopause, with vaginal dryness

Group Type EXPERIMENTAL

Hyaluronic acid - Research product 1

Intervention Type OTHER

Health care product (intimate gel)

Hyaluronic acid - Research product 2

Intervention Type OTHER

Health care product (intimate gel)

Hyaluronic acid - Comparator product

Intervention Type OTHER

Health care product (intimate gel)

climacteric women

Health volunteers, climacteric, with vaginal dryness

Group Type ACTIVE_COMPARATOR

Hyaluronic acid - Research product 1

Intervention Type OTHER

Health care product (intimate gel)

Hyaluronic acid - Research product 2

Intervention Type OTHER

Health care product (intimate gel)

Hyaluronic acid - Comparator product

Intervention Type OTHER

Health care product (intimate gel)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hyaluronic acid - Research product 1

Health care product (intimate gel)

Intervention Type OTHER

Hyaluronic acid - Research product 2

Health care product (intimate gel)

Intervention Type OTHER

Hyaluronic acid - Comparator product

Health care product (intimate gel)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Health volunteers
* Non-injured mucosa in the test region;
* Agreement to adhere to study procedures and requirements and attend the institute on the day(s) and time(s) determined for the evaluations;
* Ability to consent to their participation in the study;
* Age from 18 to 70 years old;
* Female participants;
* Vaginal dryness (slight minimum) - according to questions from the gynecologist.

Exclusion Criteria

* Pregnancy or breastfeeding;
* Skin pathology in the area of application of the product;
* Diabetes Mellitus type 1; insulin-dependent diabetes; presence of complications due to diabetes (retinopathy, nephropathy, neuropathy); presence of diabetes-related dermatoses (plantar ulcer, lipoid necrobiosis, annular granuloma, opportunistic infections); history of episodes of hypoglycemia, diabetic ketoacidosis and/or hyperosmolar coma;
* Current use of the following medications for topical or systemic use:

corticosteroids, immunosuppressants and antihistamines;

* Skin diseases: vitiligo, psoriasis, lupus, atopic dermatitis;
* History of reaction to the category of the tested product;
* Other diseases or medications that may directly interfere with the study or endanger the health of the research participant.
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Herbarium Laboratorio Botanico Ltda

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Allergisa Pesquisa Dermato-Cosmética Ltda

Campinas, , Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

All-S-EP-076888

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Vaginal Preparation Prior to Hysterectomy
NCT03412734 TERMINATED PHASE4